Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART. [electronic resource]
Producer: 20140612Description: 1-9 p. digitalISSN:- 1528-4336
- Adult
- Alkynes
- Anti-HIV Agents -- therapeutic use
- Atazanavir Sulfate
- Benzoxazines -- therapeutic use
- CD4 Lymphocyte Count
- Carbamates -- therapeutic use
- Cohort Studies
- Cyclopropanes
- Darunavir
- Drug Therapy, Combination
- Female
- Furans
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- therapeutic use
- HIV-1 -- drug effects
- Humans
- Lipids -- blood
- Lopinavir -- therapeutic use
- Male
- Middle Aged
- Nitriles
- Oligopeptides -- therapeutic use
- Organophosphates -- therapeutic use
- Pyridazines -- therapeutic use
- Pyridines -- therapeutic use
- Pyrimidines
- Reverse Transcriptase Inhibitors -- therapeutic use
- Ritonavir -- therapeutic use
- Spain
- Sulfonamides -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.